AI assistant
CVS HEALTH Corp — Director's Dealing 2017
Mar 2, 2017
29875_dirs_2017-03-02_69d0ad93-395b-44e3-b2a6-5c80e2d61a78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2017-02-28
Reporting Person: Boratto Eva C (SVP, Cont & Chief Acct Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-28 | Common Stock (restricted) | A | 1385 | $80.58 | Acquired | 16831 | Direct |
| 2017-02-28 | Common Stock | A | 2482 | $80.58 | Acquired | 36413.1476 | Direct |
| 2017-02-28 | Common Stock | F | 828 | $80.58 | Disposed | 35585.1476 | Direct |
Footnotes
F1: Consists of Restricted Stock Units awarded pursuant to Issuer's 2010 Incentive Compensation Plan and its Performance-Based Restricted Stock Unit Plan. Restrictions lapse in three equal installments, commencing February 28, 2018.
F2: Consists of stock awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.
F3: Surrender of shares in payment of withholding taxes due upon the vesting of a stock award under the Registrant's 2010 Incentive Compensation Plan and its Long-Term Incentive Plan.